TCON
TRACON Pharmaceuticals, Inc. Common Stock
TCON
TCON
Delisted
TCON was delisted on the 27th of June, 2024.
31 hedge funds and large institutions have $19.7M invested in TRACON Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% less capital invested
Capital invested by funds: $24M → $19.7M (-$4.27M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Holders
31
Holding in Top 10
1
Calls
$125K
Puts
$47K
Top Buyers
| 1 | +$1.94M | |
| 2 | +$150K | |
| 3 | +$66K | |
| 4 |
Renaissance Technologies
New York
|
+$46.7K |
| 5 |
BlackRock
New York
|
+$11.6K |
Top Sellers
| 1 | -$150K | |
| 2 | -$131K | |
| 3 | -$115K | |
| 4 |
IC
Ikarian Capital
Dallas,
Texas
|
-$109K |
| 5 |
Two Sigma Advisers
New York
|
-$97K |